期刊文献+

溶质在磷脂膜色谱与正辛醇/水系统中的热力学分配行为 被引量:2

Thermodynamic Partitioning Behavior for Solutes into Immobilized Artificial Membrane or an n-Octanol/Water System
在线阅读 下载PDF
导出
摘要 The thermodynamic partitioning behavior of solutes into immobilized artificial membrane(IAM) and n-octanol/water systems was investigated, including acidic,basic,and amphoteric substances.In an n-octanol/buffer system,partitioning process was entropy-dominated for the most studied drugs,while partitioning of oxolinic and nalidixic acids into n-octanol phase was enthalpy-driven.In IAM chromatography,partitioning into membrane for the studied solutes was enthalpy-driven and an exothermal process.In conclusion,there is a significant difference of solutes′ partitioning mechanism into either IAM or an n-octanol phase,therefore,presenting the theoretical basis for differing lipophilicity measuring scale. The thermodynamic partitioning behavior of solutes into immobilized artificial membrane(IAM) and n-octanol/water systems was investigated, including acidic, basic, and amphoteric substances. In an n-octanol/buffer system, partitioning process was entropy-dominated for the most studied drugs, while partitioning of oxolinic and nalidixic acids into n-octanol phase was enthalpy-driven. In IAM chromatography, partitioning into membrane for the studied solutes was enthalpy-driven and an exothermal process. In conclusion, there is a significant difference of solutes' partitioning mechanism into either IAM or an n-octanol phase, therefore, presenting the theoretical basis for differing lipophilicity measuring scale.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2006年第2期349-351,共3页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:30400563)资助
关键词 热力学分配行为 磷脂膜色谱 正辛醇/水 膜作用 Thermodynamic partitioning behavior IAM chromatography n-Octanol/water system Membrane interactions
  • 相关文献

参考文献11

  • 1Ong S. , IAu H. , Pidgeon C.. J. Chromatogr. A[J]. 1996, 728:113-128.
  • 2SUNJin(孙进) WANGShu-Jun(王淑君) CHENGGang(程刚)etal.药学学报,2003,38:475-475.
  • 3Yang C. Y. , Cai S. J. , Liu H. L. et al.. Adv. Drug Del. Rev. [J]. 1996, 23:229-256.
  • 4SUNJin(孙进) CHENGGang(程剐) HEZhong-Gui(何仲贵)etal.药学学报,2003,38:791-794.
  • 5SUNJin(孙进) CHENGGang(程刚) HEZhong Gui(何仲贵)etal.药学学报,2003,38:702-702.
  • 6Sun J. , Deguchi Y. , Chert J. M. et al.. Aeta Pharmacol. Sin. [J]. 2002, 23:430-438.
  • 7Ottiger C. , Wunderli-Allenspach H.. Pharm. Res. [J]. 1999, 16:643-650.
  • 8Rogers J. A., Wong A.. Int. J. Pharm. [J]. 1980,6:339-348.
  • 9Sun J. , Sakai S. , Tauchi Y. et al.. Eur. J. Pharm. Biopharm. [J]. 2003, 12: 223-229.
  • 10Sun J. , Cheng G. , He Z, G. et al., J. Chin. Pharm. Sci. [J]. 2003, 12:25-30.

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部